NCT00081653 - A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva | Biotech Hunter

Enrollment

719

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

May 31, 2008

Conditions

Post-Menopausal Osteoporosis

Interventions

DRUG

ibandronate [Bonviva/Boniva]

150mg po monthly for 3 years

DRUG

ibandronate [Bonviva/Boniva]

100mg po monthly for 3 years

Trial Locations (31)

1036

Budapest

1083

Budapest

2170

Merksem

2750

Ballerup Municipality

4010

Stavanger

4020

Liège

5507

Haugesund

6400

Kiskunhalas

7100

Vejle

8230

Balatonfüred

8900

Zalaegerszeg

9000

Aalborg

12200

Berlin

28041

Madrid

30167

Hanover

37000

León

53100

Siena

68131

Omaha

69000

Lyon

80260

Lakewood

85100

Obregón

92357

Loma Linda

97213

Portland

07039

Livingston

04026-000

São Paulo

305 99

Pilsen

128 00

Prague

31-501

Krakow

04-730

Warsaw

08907

Barcelona

SO16 6YD

Southampton

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY